These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 20026449

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J, Jensen KT, Follmann F, Agger EM, Theisen M, Andersen P.
    J Infect Dis; 2008 Sep 01; 198(5):758-67. PubMed ID: 18652549
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM.
    Vaccine; 2006 Feb 06; 24(6):766-75. PubMed ID: 16199110
    [Abstract] [Full Text] [Related]

  • 7. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW, Hafner LM, Beagley KW, Timms P.
    J Reprod Immunol; 2011 Sep 06; 91(1-2):9-16. PubMed ID: 21856018
    [Abstract] [Full Text] [Related]

  • 8. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
    Pal S, Tatarenkova OV, de la Maza LM.
    Immunology; 2015 Nov 06; 146(3):432-43. PubMed ID: 26423798
    [Abstract] [Full Text] [Related]

  • 9. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP.
    Infect Immun; 2007 Feb 06; 75(2):666-76. PubMed ID: 17118987
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
    Berry LJ, Hickey DK, Skelding KA, Bao S, Rendina AM, Hansbro PM, Gockel CM, Beagley KW.
    Infect Immun; 2004 Feb 06; 72(2):1019-28. PubMed ID: 14742549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO.
    J Microbiol Immunol Infect; 2007 Jun 06; 40(3):188-200. PubMed ID: 17639158
    [Abstract] [Full Text] [Related]

  • 14. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosa.
    Schautteet K, Stuyven E, Beeckman DS, Van Acker S, Carlon M, Chiers K, Cox E, Vanrompay D.
    Vaccine; 2011 Feb 04; 29(7):1399-407. PubMed ID: 21195805
    [Abstract] [Full Text] [Related]

  • 15. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S, Luke CJ, Barbour AG, Peterson EM, de la Maza LM.
    Vaccine; 2003 Mar 28; 21(13-14):1455-65. PubMed ID: 12615442
    [Abstract] [Full Text] [Related]

  • 16. Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection.
    Cong Y, Jupelli M, Guentzel MN, Zhong G, Murthy AK, Arulanandam BP.
    Vaccine; 2007 May 10; 25(19):3773-80. PubMed ID: 17349723
    [Abstract] [Full Text] [Related]

  • 17. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.
    Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate.
    Hickey DK, Jones RC, Bao S, Blake AE, Skelding KA, Berry LJ, Beagley KW.
    Vaccine; 2004 Oct 22; 22(31-32):4306-15. PubMed ID: 15474723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.